{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:42:14Z","timestamp":1791430934132,"version":"4.3.3"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2023\\u20130163"],"award-info":[{"award-number":["FO2023\\u20130163"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2024\\u20130284"],"award-info":[{"award-number":["FO2024\\u20130284"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2025\\u20130055"],"award-info":[{"award-number":["FO2025\\u20130055"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2021\\u20130293"],"award-info":[{"award-number":["FO2021\\u20130293"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2022\\u20130204"],"award-info":[{"award-number":["FO2022\\u20130204"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006129","name":"King Gustaf V and Queen Victoria's Masonic Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lunds Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021728","name":"Bundy Academy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011077","name":"Sk\u00e5ne University Hospital Lund","doi-asserted-by":"publisher","award":["2020-O000028"],"award-info":[{"award-number":["2020-O000028"]}],"id":[{"id":"10.13039\/501100011077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["AF-968598"],"award-info":[{"award-number":["AF-968598"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["AF-1,011949"],"award-info":[{"award-number":["AF-1,011949"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["AF-980907"],"award-info":[{"award-number":["AF-980907"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["AF-981132"],"award-info":[{"award-number":["AF-981132"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["AF-1,011799"],"award-info":[{"award-number":["AF-1,011799"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["ADG- 101096455"],"award-info":[{"award-number":["ADG- 101096455"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-02052"],"award-info":[{"award-number":["2018-02052"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-00775"],"award-info":[{"award-number":["2022-00775"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-00905"],"award-info":[{"award-number":["2021-00905"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["ERAPERMED2021\\u2013184"],"award-info":[{"award-number":["ERAPERMED2021\\u2013184"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2017-01541"],"award-info":[{"award-number":["2017-01541"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-02219"],"award-info":[{"award-number":["2021-02219"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["ZEN24\\u20131,069572"],"award-info":[{"award-number":["ZEN24\\u20131,069572"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["ALZSI-26\\u20131,523522"],"award-info":[{"award-number":["ALZSI-26\\u20131,523522"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["SG-23\\u20131,061717"],"award-info":[{"award-number":["SG-23\\u20131,061717"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006075","name":"Greta och Johan Kocks stiftelser","doi-asserted-by":"publisher","award":["WASP\/DDLS22\\u2013066"],"award-info":[{"award-number":["WASP\/DDLS22\\u2013066"]}],"id":[{"id":"10.13039\/501100006075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-025507"],"award-info":[{"award-number":["MJFF-025507"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","award":["2022-0231"],"award-info":[{"award-number":["2022-0231"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","award":["2017-0383"],"award-info":[{"award-number":["2017-0383"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015595","name":"GHR Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","award":["1412\/22"],"award-info":[{"award-number":["1412\/22"]}],"id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","award":["1280\/20"],"award-info":[{"award-number":["1280\/20"]}],"id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.tjpad.2025.100448","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T01:03:07Z","timestamp":1767229387000},"page":"100448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-\u03b2 and tau - a prospective cohort study"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4061-7534","authenticated-orcid":false,"given":"Isabelle","family":"Glans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Mattsson-Carlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Strandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Stomrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Ossenkoppele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8649-9874","authenticated-orcid":false,"given":"Danielle","family":"van Westen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5404-8788","authenticated-orcid":false,"given":"Nicola","family":"Spotorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Palmqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2025.100448_bib0001","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.tjpad.2025.100448_bib0002","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100448_bib0003","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/brain\/awt188","article-title":"Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre","volume":"136","author":"Toledo","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.tjpad.2025.100448_bib0004","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1212\/WNL.0b013e31826c1b9d","article-title":"Vascular burden and Alzheimer disease pathologic progression","volume":"79","author":"Lo","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100448_bib0005","doi-asserted-by":"crossref","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 2012 Jan;8(1):1-13. doi:10.1016\/j.jalz.2011.10.007. PMID: 22265587; PMCID: PMC3266529.","DOI":"10.1016\/j.jalz.2011.10.007"},{"key":"10.1016\/j.tjpad.2025.100448_bib0006","doi-asserted-by":"crossref","unstructured":"Jack C.R., Jr., Andrews J.S., Beach T.G., et al. Revised criteria for diagnosis and staging of Alzheimer's disease: alzheimer's Association Workgroup. Alzheimers Dement. 2024 Aug;20(8):5143-5169. doi:10.1002\/alz.13859. Epub 2024 Jun 27. PMID: 38934362; PMCID: PMC11350039.","DOI":"10.1002\/alz.13859"},{"issue":"10004","key":"10.1016\/j.tjpad.2025.100448_bib0007","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","article-title":"Vascular dementia","volume":"386","author":"O'Brien","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.tjpad.2025.100448_bib0008","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2025.100448_bib0009","doi-asserted-by":"crossref","unstructured":"Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997 Mar;28(3):652-9. doi:10.1161\/01.str.28.3.652. PMID: 9056627.","DOI":"10.1161\/01.STR.28.3.652"},{"key":"10.1016\/j.tjpad.2025.100448_bib0010","doi-asserted-by":"crossref","unstructured":"Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010 Jul;9(7):689-701. doi:10.1016\/S1474-4422(10)70104-6. PMID: 20610345.","DOI":"10.1016\/S1474-4422(10)70104-6"},{"key":"10.1016\/j.tjpad.2025.100448_bib0011","doi-asserted-by":"crossref","unstructured":"Brown R, Low A, Markus HS. Rate of, and risk factors for, white matter hyperintensity growth: a systematic review and meta-analysis with implications for clinical trial design. J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1271-1277. doi:10.1136\/jnnp-2021-326569. Epub 2021 Aug 3. PMID: 34344790.","DOI":"10.1136\/jnnp-2021-326569"},{"key":"10.1016\/j.tjpad.2025.100448_bib0012","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jalz.2019.04.015","article-title":"Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease","volume":"15","author":"Bos","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100448_bib0013","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1212\/WNL.0b013e318238eec1","article-title":"Alzheimer disease biomarkers are associated with body mass index","volume":"77","author":"Vidoni","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100448_bib0014","article-title":"Associations of the Lifestyle for Brain Health index with longitudinal cognition and brain amyloid beta in clinically unimpaired older adults: findings from the Wisconsin Registry for Alzheimer's Prevention","volume":"14","author":"Cody","year":"2022","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.tjpad.2025.100448_bib0015","doi-asserted-by":"crossref","unstructured":"Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011 Sep;10(9):819-28. doi:10.1016\/S1474-4422(11)70072-2. Epub 2011 Jul 19. PMID: 21775213; PMCID: PMC3647614.","DOI":"10.1016\/S1474-4422(11)70072-2"},{"key":"10.1016\/j.tjpad.2025.100448_bib0016","doi-asserted-by":"crossref","unstructured":"Coughlan GT, Klinger HM, Boyle R, Betthauser TJ, Binette AP, Christenson L, Chadwick T, Hansson O, Harrison TM, Healy B, Jacobs HIL, Hanseeuw B, Jonaitis E, Jack CR Jr, Johnson KA, Langhough RE, Properzi MJ, Rentz DM, Schultz AP, Smith R, Seto M, Johnson SC, Mielke MM, Shirzadi Z, Yau WW, Manson JE, Sperling RA, Vemuri P, Buckley RF; Alzheimer\u2019s Disease Neuroimaging Initiative. Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-Analysis. JAMA Neurol. 2025 Mar 3;82(4):364\u201375. doi:10.1001\/jamaneurol.2025.0013. Epub ahead of print. PMID: 40029638; PMCID: PMC11877413.","DOI":"10.1001\/jamaneurol.2025.0013"},{"key":"10.1016\/j.tjpad.2025.100448_bib0017","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/brain\/awad397","article-title":"Sex-specific modulation of amyloid-\u03b2 on tau phosphorylation underlies faster tangle accumulation in females","volume":"147","author":"Wang","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.tjpad.2025.100448_bib0018","doi-asserted-by":"crossref","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, Su Y, Chen Y, Serrano GE, Leuzy A, Mattsson-Carlgren N, Strandberg O, Smith R, Villegas A, Sepulveda-Falla D, Chai X, Proctor NK, Beach TG, Blennow K, Dage JL, Reiman EM, Hansson O. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA. 2020 Aug 25;324(8):772-781. doi:10.1001\/jama.2020.12134. PMID: 32722745; PMCID: PMC7388060.","DOI":"10.1001\/jama.2020.12134"},{"key":"10.1016\/j.tjpad.2025.100448_bib0019","doi-asserted-by":"crossref","unstructured":"Palmqvist S, Rossi M, Hall S, Quadalti C, Mattsson-Carlgren N, Dellavalle S, Tideman P, Pereira JB, Nilsson MH, Mammana A, Janelidze S, Baiardi S, Stomrud E, Parchi P, Hansson O. Cognitive effects of Lewy body pathology in clinically unimpaired individuals. Nat Med. 2023 Aug;29(8):1971-1978. doi:10.1038\/s41591-023-02450-0. Epub 2023 Jul 18. PMID: 37464059; PMCID: PMC10427420.","DOI":"10.1038\/s41591-023-02450-0"},{"key":"10.1016\/j.tjpad.2025.100448_bib0020","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0140-6736(05)64501-1","article-title":"APOE genotyping in differential diagnosis of Alzheimer's disease","volume":"348","author":"Slooter","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.tjpad.2025.100448_bib0021","doi-asserted-by":"crossref","unstructured":"Hansson O, Seibyl J, Stomrud E, Zetterberg H, Trojanowski JQ, Bittner T, Lifke V, Corradini V, Eichenlaub U, Batrla R, Buck K, Zink K, Rabe C, Blennow K, Shaw LM; Swedish BioFINDER study group; Alzheimer's Disease Neuroimaging Initiative. CSF biomarkers of Alzheimer's disease concord with amyloid-\u03b2 PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement. 2018 Nov;14(11):1470-1481. doi:10.1016\/j.jalz.2018.01.010. Epub 2018 Mar 1. PMID: 29499171; PMCID: PMC6119541.","DOI":"10.1016\/j.jalz.2018.01.010"},{"key":"10.1016\/j.tjpad.2025.100448_bib0022","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/alz.12316","article-title":"The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid beta and tau","volume":"17","author":"Hansson","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100448_bib0023","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer's disease concord with amyloid-beta PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100448_bib0024","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/alz.12395","article-title":"Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Abeta42\/Abeta40 and p-tau","volume":"18","author":"Janelidze","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100448_bib0025","doi-asserted-by":"crossref","unstructured":"Ahmadi K, Pereira JB, van Westen D, Pasternak O, Zhang F, Nilsson M, Stomrud E, Spotorno N, Hansson O. Fixel-Based Analysis Reveals Tau-Related White Matter Changes in Early Stages of Alzheimer's Disease. J Neurosci. 2024 May 1;44(18):e0538232024. doi:10.1523\/JNEUROSCI.0538-23.2024. PMID: 38565289; PMCID: PMC11063818.","DOI":"10.1523\/JNEUROSCI.0538-23.2024"},{"key":"10.1016\/j.tjpad.2025.100448_bib0026","unstructured":"Fazekas F Fau, Chawluk J.B., Chawluk Jb Fau, Alavi A., Alavi A Fau, Hurtig H.I., Hurtig Hi Fau, Zimmerman R.A., Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging."},{"key":"10.1016\/j.tjpad.2025.100448_bib0027","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.dib.2017.10.024","article-title":"Considerations and code for partial volume correcting [(18)F]-AV-1451 tau PET data","volume":"15","author":"Baker","year":"2017","journal-title":"Data Brief"},{"key":"10.1016\/j.tjpad.2025.100448_bib0028","doi-asserted-by":"crossref","unstructured":"Leuzy A, Smith R, Ossenkoppele R, Santillo A, Borroni E, Klein G, Ohlsson T, J\u00f6gi J, Palmqvist S, Mattsson-Carlgren N, Strandberg O, Stomrud E, Hansson O. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders. JAMA Neurol. 2020 Aug 1;77(8):955-965. doi:10.1001\/jamaneurol.2020.0989. PMID: 32391858; PMCID: PMC7215644.","DOI":"10.1001\/jamaneurol.2020.0989"},{"key":"10.1016\/j.tjpad.2025.100448_bib0029","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study","volume":"21","author":"Charidimou","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2025.100448_bib0030","doi-asserted-by":"crossref","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD Sr, Jagust WJ, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, Rowe CC, Skovronsky DM, Mintun MA. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4. doi:10.1016\/j.jalz.2014.07.003. Epub 2014 Oct 28. PMID: 25443857; PMCID: PMC4300247.","DOI":"10.1016\/j.jalz.2014.07.003"},{"key":"10.1016\/j.tjpad.2025.100448_bib0031","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.tjpad.2025.100448_bib0032","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamaneurol.2019.3774","article-title":"Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: evidence From a British Birth Cohort","volume":"77","author":"Lane","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100448_bib0033","doi-asserted-by":"crossref","unstructured":"Mukadam N, Wolters FJ, Walsh S, Wallace L, Brayne C, Matthews FE, Sacuiu S, Skoog I, Seshadri S, Beiser A, Ghosh S, Livingston G. Changes in prevalence and incidence of dementia and risk factors for dementia: an analysis from cohort studies. Lancet Public Health. 2024 Jul;9(7):e443-e460. doi:10.1016\/S2468-2667(24)00120-8. Erratum in: Lancet Public Health. 2024 Oct;9(10):e718. doi:10.1016\/S2468-2667(24)00212-3. PMID: 38942556.","DOI":"10.1016\/S2468-2667(24)00120-8"},{"key":"10.1016\/j.tjpad.2025.100448_bib0034","doi-asserted-by":"crossref","unstructured":"Cao Y, Huang MY, Mao CH, Wang X, Xu YY, Qian XJ, Ma C, Qiu WY, Zhu YC. Arteriolosclerosis differs from venular collagenosis in relation to cerebrovascular parenchymal damages: an autopsy-based study. Stroke Vasc Neurol. 2023 Aug;8(4):267-275. doi:10.1136\/svn-2022-001924. Epub 2022 Dec 29. PMID: 36581493; PMCID: PMC10512076.","DOI":"10.1136\/svn-2022-001924"},{"key":"10.1016\/j.tjpad.2025.100448_bib0035","doi-asserted-by":"crossref","unstructured":"Costa ED, Silva JF, Garcia DC, Wainstein AJ, Rezende BA, Tostes RC, Teixeira MM, Cortes SF, Lemos VS. Decreased expression of neuronal nitric oxide synthase contributes to the endothelial dysfunction associated with cigarette smoking in human. Nitric Oxide. 2020 May 1;98:20-28. doi:10.1016\/j.niox.2020.02.003. Epub 2020 Feb 25. PMID: 32109572.","DOI":"10.1016\/j.niox.2020.02.003"},{"key":"10.1016\/j.tjpad.2025.100448_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnha.2024.100444","article-title":"Alzheimer's Disease Neuroimaging I. Impact of diabetes on the progression of Alzheimer's disease via trajectories of amyloid-tau-neurodegeneration (ATN) biomarkers","volume":"29","author":"Kim","year":"2025","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.tjpad.2025.100448_bib0037","doi-asserted-by":"crossref","unstructured":"Byun MS, Kim HJ, Yi D, Choi HJ, Baek H, Lee JH, Choe YM, Sohn BK, Lee JY, Lee Y, Ko H, Kim YK, Lee YS, Sohn CH, Woo JI, Lee DY; KBASE Research Group. Differential effects of blood insulin and HbA1c on cerebral amyloid burden and neurodegeneration in nondiabetic cognitively normal older adults. Neurobiol Aging. 2017 Nov;59:15-21. doi:10.1016\/j.neurobiolaging.2017.07.004. Epub 2017 Jul 20. PMID: 28780367.","DOI":"10.1016\/j.neurobiolaging.2017.07.004"},{"key":"10.1016\/j.tjpad.2025.100448_bib0038","doi-asserted-by":"crossref","unstructured":"Moran C, Beare R, Phan TG, Bruce DG, Callisaya ML, Srikanth V; Alzheimer's Disease Neuroimaging Initiative (ADNI). Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology. 2015 Sep 29;85(13):1123-30. doi:10.1212\/WNL.0000000000001982. Epub 2015 Sep 2. PMID: 26333802; PMCID: PMC5573049.","DOI":"10.1212\/WNL.0000000000001982"},{"key":"10.1016\/j.tjpad.2025.100448_bib0039","doi-asserted-by":"crossref","unstructured":"Besser LM, Alosco ML, Ramirez Gomez L, Zhou XH, McKee AC, Stern RA, Gunstad J, Schneider JA, Chui H, Kukull WA. Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal Cognition. J Neuropathol Exp Neurol. 2016 Oct;75(10):955-962. doi:10.1093\/jnen\/nlw072. Epub 2016 Aug 11. PMID: 27516116; PMCID: PMC5029440.","DOI":"10.1093\/jnen\/nlw072"},{"key":"10.1016\/j.tjpad.2025.100448_bib0040","doi-asserted-by":"crossref","unstructured":"Sonnen JA, Larson EB, Brickell K, Crane PK, Woltjer R, Montine TJ, Craft S. Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol. 2009 Mar;66(3):315-22. doi:10.1001\/archneurol.2008.579. Epub 2009 Jan 12. PMID: 19139294; PMCID: PMC2766529.","DOI":"10.1001\/archneurol.2008.579"},{"key":"10.1016\/j.tjpad.2025.100448_bib0041","doi-asserted-by":"crossref","unstructured":"Pruzin JJ, Schneider JA, Capuano AW, Leurgans SE, Barnes LL, Ahima RS, Arnold SE, Bennett DA, Arvanitakis Z. Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology. Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):41-47. doi:10.1097\/WAD.0000000000000172. PMID: 27755004; PMCID: PMC5321787.","DOI":"10.1097\/WAD.0000000000000172"},{"key":"10.1016\/j.tjpad.2025.100448_bib0042","doi-asserted-by":"crossref","unstructured":"Abner EL, Nelson PT, Kryscio RJ, Schmitt FA, Fardo DW, Woltjer RL, Cairns NJ, Yu L, Dodge HH, Xiong C, Masaki K, Tyas SL, Bennett DA, Schneider JA, Arvanitakis Z. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology. Alzheimers Dement. 2016 Aug;12(8):882-9. doi:10.1016\/j.jalz.2015.12.006. Epub 2016 Jan 23. PMID: 26812281; PMCID: PMC4958598.","DOI":"10.1016\/j.jalz.2015.12.006"},{"key":"10.1016\/j.tjpad.2025.100448_bib0043","doi-asserted-by":"crossref","unstructured":"Michailidis M, Moraitou D, Tata DA, Kalinderi K, Papamitsou T, Papaliagkas V. Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes. Int J Mol Sci. 2022 Feb 28;23(5):2687. doi:10.3390\/ijms23052687. PMID: 35269827; PMCID: PMC8910482.","DOI":"10.3390\/ijms23052687"},{"key":"10.1016\/j.tjpad.2025.100448_bib0044","doi-asserted-by":"crossref","unstructured":"Wang W, Wang Q, Qi X, Gurney M, Perry G, Volkow ND, Davis PB, Kaelber DC, Xu R. Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US. Alzheimers Dement. 2024 Dec;20(12):8661-8672. doi:10.1002\/alz.14313. Epub 2024 Oct 24. PMID: 39445596; PMCID: PMC11667504.","DOI":"10.1002\/alz.14313"},{"key":"10.1016\/j.tjpad.2025.100448_bib0045","doi-asserted-by":"crossref","unstructured":"Cummings JL, Atri A, Feldman HH, Hansson O, Sano M, Knop FK, Johannsen P, Le\u00f3n T, Scheltens P. evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease. Alzheimers Res Ther. 2025 Jan 8;17(1):14. doi:10.1186\/s13195-024-01666-7. PMID: 39780249; PMCID: PMC11708093.","DOI":"10.1186\/s13195-024-01666-7"},{"key":"10.1016\/j.tjpad.2025.100448_bib0046","doi-asserted-by":"crossref","unstructured":"Salvad\u00f3 G, Grothe MJ, Groot C, Moscoso A, Sch\u00f6ll M, Gispert JD, Ossenkoppele R; Alzheimer\u2019s Disease Neuroimaging Initiative. Differential associations of APOE-\u03b52 and APOE-\u03b54 alleles with PET-measured amyloid-\u03b2 and tau deposition in older individuals without dementia. Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2212-2224. doi:10.1007\/s00259-021-05192-8. Epub 2021 Feb 1. PMID: 33521872; PMCID: PMC8175302.","DOI":"10.1007\/s00259-021-05192-8"},{"key":"10.1016\/j.tjpad.2025.100448_bib0047","doi-asserted-by":"crossref","unstructured":"Cicognola C, Salvad\u00f3 G, Smith R, Palmqvist S, Stomrud E, Betthauser TJ, Johnson SC, Janelidze S, Mattsson-Carlgren N, Hansson O, Pichet Binette A. APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-\u03b2. Brain. 2025 Jul 7;148(7):2373-2383. doi:10.1093\/brain\/awaf016. PMID: 39817469; PMCID: PMC12233550.","DOI":"10.1093\/brain\/awaf016"},{"key":"10.1016\/j.tjpad.2025.100448_bib0048","doi-asserted-by":"crossref","unstructured":"Smith R, Strandberg O, Mattsson-Carlgren N, Leuzy A, Palmqvist S, Pontecorvo MJ, Devous MD, Ossenkoppele R, Hansson O. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects. Brain. 2020 Dec 1;143(12):3805-3815. doi:10.1093\/brain\/awaa327. PMID: 33439987; PMCID: PMC7805812.","DOI":"10.1093\/brain\/awaa327"},{"key":"10.1016\/j.tjpad.2025.100448_bib0049","doi-asserted-by":"crossref","unstructured":"Vidoni ED, Townley RA, Honea RA, Burns JM; Alzheimer's Disease Neuroimaging Initiative. Alzheimer disease biomarkers are associated with body mass index. Neurology. 2011 Nov 22;77(21):1913-20. doi:10.1212\/WNL.0b013e318238eec1. PMID: 22105948; PMCID: PMC3233188.","DOI":"10.1212\/WNL.0b013e318238eec1"},{"key":"10.1016\/j.tjpad.2025.100448_bib0050","doi-asserted-by":"crossref","unstructured":"Lee S, Byun MS, Yi D, Kim MJ, Jung JH, Kong N, Jung G, Ahn H, Lee JY, Kang KM, Sohn CH, Lee YS, Kim YK, Lee DY; KBASE Research Group. Body mass index and two-year change of in vivo Alzheimer's disease pathologies in cognitively normal older adults. Alzheimers Res Ther. 2023 Jun 13;15(1):108. doi:10.1186\/s13195-023-01259-w. PMID: 37312229; PMCID: PMC10262499.","DOI":"10.1186\/s13195-023-01259-w"},{"key":"10.1016\/j.tjpad.2025.100448_bib0051","doi-asserted-by":"crossref","unstructured":"Tolppanen AM, Ngandu T, K\u00e5reholt I, Laatikainen T, Rusanen M, Soininen H, Kivipelto M. Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. J Alzheimers Dis. 2014;38(1):201-9. doi:10.3233\/JAD-130698. PMID: 23948937.","DOI":"10.3233\/JAD-130698"},{"key":"10.1016\/j.tjpad.2025.100448_bib0052","doi-asserted-by":"crossref","unstructured":"Sun Z, Wang ZT, Sun FR, Shen XN, Xu W, Ma YH, Dong Q, Tan L, Yu JT; Alzheimer\u2019s Disease Neuroimaging Initiative. Late-life obesity is a protective factor for prodromal Alzheimer's disease: a longitudinal study. Aging (Albany NY). 2020 Jan 25;12(2):2005-2017. doi:10.18632\/aging.102738. Epub 2020 Jan 25. PMID: 31986486; PMCID: PMC7053604.","DOI":"10.18632\/aging.102738"},{"key":"10.1016\/j.tjpad.2025.100448_bib0053","doi-asserted-by":"crossref","unstructured":"Knight EM, Verkhratsky A, Luckman SM, Allan SM, Lawrence CB. Hypermetabolism in a triple-transgenic mouse model of Alzheimer's disease. Neurobiol Aging. 2012 Jan;33(1):187-93. doi:10.1016\/j.neurobiolaging.2010.02.003. Epub 2010 Mar 31. PMID: 20359775.","DOI":"10.1016\/j.neurobiolaging.2010.02.003"},{"key":"10.1016\/j.tjpad.2025.100448_bib0054","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41598-017-01327-w","article-title":"Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease","volume":"7","author":"Muller","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.tjpad.2025.100448_bib0055","doi-asserted-by":"crossref","unstructured":"Koohi F, Harshfield EL, Gill D, Ge W, Burgess S, Markus HS. Optimizing treatment of cardiovascular risk factors in cerebral small vessel disease using genetics. Brain. 2025 Jun 3;148(6):1936-1949. doi:10.1093\/brain\/awae399. PMID: 39661645; PMCID: PMC7617411.","DOI":"10.1093\/brain\/awae399"},{"key":"10.1016\/j.tjpad.2025.100448_bib0056","doi-asserted-by":"crossref","unstructured":"Park C, Kang C. Does education induce healthy lifestyle? J Health Econ. 2008 Dec;27(6):1516-31. doi:10.1016\/j.jhealeco.2008.07.005. Epub 2008 Jul 23. PMID: 18963121.","DOI":"10.1016\/j.jhealeco.2008.07.005"},{"key":"10.1016\/j.tjpad.2025.100448_bib0057","doi-asserted-by":"crossref","unstructured":"Alves J, Perelman J, Ramos E, Kunst AE. The emergence of socioeconomic inequalities in smoking during adolescence and early adulthood. BMC Public Health. 2023 Jul 18;23(1):1382. doi:10.1186\/s12889-023-16182-w. PMID: 37464370; PMCID: PMC10354878.","DOI":"10.1186\/s12889-023-16182-w"},{"key":"10.1016\/j.tjpad.2025.100448_bib0058","doi-asserted-by":"crossref","unstructured":"Rochoy M, Rivas V, Chazard E, Decarpentry E, Saudemont G, Hazard PA, Puisieux F, Gautier S, Bordet R. Factors Associated with Alzheimer's Disease: An Overview of Reviews. J Prev Alzheimers Dis. 2019;6(2):121-134. doi:10.14283\/jpad.2019.7. PMID: 30756119.","DOI":"10.14283\/jpad.2019.7"},{"key":"10.1016\/j.tjpad.2025.100448_bib0059","doi-asserted-by":"crossref","unstructured":"Bocancea DI, Svenningsson AL, van Loenhoud AC, Groot C, Barkhof F, Strandberg O, Smith R; Alzheimer\u2019s Disease Neuroimaging Initiative; La Joie R, Rosen HJ, Pontecorvo MJ, Rabinovici GD, van der Flier WM, Hansson O, Ossenkoppele R. Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis. Brain. 2023 Sep 1;146(9):3719-3734. doi:10.1093\/brain\/awad100. PMID: 36967222; PMCID: PMC10473572.","DOI":"10.1093\/brain\/awad100"},{"key":"10.1016\/j.tjpad.2025.100448_bib0060","doi-asserted-by":"crossref","unstructured":"Son S, Speechley M, Zou GY, Kivipelto M, Mangialasche F, Feldman HH, Chertkow H, Belleville S, Nygaard H, Hachinski V, Pieruccini-Faria F, Montero-Odasso M. Potentially Modifiable Dementia Risk Factors in Canada: An Analysis of Canadian Longitudinal Study on Aging with a Multi-Country Comparison. J Prev Alzheimers Dis. 2024;11(5):1490-1499. doi:10.14283\/jpad.2024.105. PMID: 39350396; PMCID: PMC11436427.","DOI":"10.14283\/jpad.2024.105"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725003899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725003899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:45:53Z","timestamp":1778867153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725003899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2274580725003899"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100448","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-\u03b2 and tau - a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100448"}}